Population
Patients with atrial fibrillation and active cancer
Design
Editorial
Authors
Loading...
Due to a lack of dedicated RCTs, decision-making for anticoagulation in patients with AF and active cancer requires an individualized approach based on thrombosis risk, bleeding risk, drug interactions, and patient preference (the TBIP approach).
Due to a lack of dedicated RCTs, decision-making for anticoagulation in patients with AF and active cancer requires an individualized approach based on thrombosis risk, bleeding risk, drug interactions, and patient preference (the TBIP approach).
Dimitrios Farmakis (2020) studied this question.